Histone deacetylase inhibitors prevent activation of tumour-reactive NK cells and T cells but do not interfere with their cytolytic effector functions.
Schmudde
Mareike
M
Institute for Immunology and Transfusion Medicine, Ernst Moritz Arndt University Greifswald, Germany. mareike.schmudde@uni-greifswald.de
Friebe
Erika
E
Sonnemann
Jürgen
J
Beck
James F
JF
Bröker
Barbara M
BM